These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5925255)

  • 21. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor.
    Krakoff IH; Murphy ML
    Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486
    [No Abstract]   [Full Text] [Related]  

  • 22. Xanthine oxidase inhibition in the management of hyperuricemia in leukemias and lymphomas.
    Krakoff IH
    Arthritis Rheum; 1965 Oct; 8(5):897-8. PubMed ID: 5859560
    [No Abstract]   [Full Text] [Related]  

  • 23. Prophylaxis of idiopathic and gouty uric acid lithiasis by allopurinol.
    de Vries A; Frank M
    Urol Int; 1967; 22(6):506-16. PubMed ID: 5590840
    [No Abstract]   [Full Text] [Related]  

  • 24. The development of allopurinol.
    Rundles RW
    Arch Intern Med; 1985 Aug; 145(8):1492-503. PubMed ID: 3896181
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hyperuricosuria controlled with allopurinol: a new concept in the prevention of uric acid calculi].
    Anderson EE; Rudles RW; Silberman HR; Martinez SJ
    Rev Venez Urol; 1970; 22(3):265-73. PubMed ID: 5519834
    [No Abstract]   [Full Text] [Related]  

  • 26. Allopurinol in treatment of gout.
    Scott JT; Hall AP; Grahame R
    Br Med J; 1966 Aug; 2(5509):321-7. PubMed ID: 5920652
    [No Abstract]   [Full Text] [Related]  

  • 27. Asymptomatic hyperuricemia. The case for benign neglect.
    Littman BH
    Postgrad Med; 1985 May; 77(6):221-4. PubMed ID: 3991381
    [No Abstract]   [Full Text] [Related]  

  • 28. Allopurinal and acute uric acid nephropathy.
    Watts RW; Watkins PJ; Matthias JQ; Gibbs DA
    Br Med J; 1966 Jan; 1(5481):205-8. PubMed ID: 5901729
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperuricosuria and urolithiasis].
    Koide T
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)].
    Vigo P; Ortolani S; Soldati L; Girardello R; Fleischmann L; Polli EE
    Haematologica; 1981 Oct; 66(5):656-66. PubMed ID: 6796473
    [No Abstract]   [Full Text] [Related]  

  • 31. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
    [No Abstract]   [Full Text] [Related]  

  • 33. Allopurinol in the treatment of uraemic patients with gout.
    Wilson JD; Simmonds HA; North JD
    Ann Rheum Dis; 1967 Mar; 26(2):136-42. PubMed ID: 6023695
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical evidence for a distinct type of primary gout.
    Sorensen LB; Benke PJ
    Nature; 1967 Mar; 213(5081):1122-3. PubMed ID: 6029792
    [No Abstract]   [Full Text] [Related]  

  • 35. [Allopurinol in the prevention and treatment of urate complications in leukemia].
    Aldo C; Roberto M
    Haematologica; 1969; 54(1):17-28. PubMed ID: 4978717
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of gout by reduction of uric acid production.
    Kersley GD
    Ann Rheum Dis; 1966 Jul; 25(4):353-5. PubMed ID: 5947580
    [No Abstract]   [Full Text] [Related]  

  • 37. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
    [No Abstract]   [Full Text] [Related]  

  • 39. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of gout with allopurinol. (Study of 106 cases)].
    Delbarre F; Auscher C; Amor B; de Géry A
    Sem Hop; 1967 Feb; 43(10):634-43. PubMed ID: 4292982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.